20260240 - Acquisition of Reagents for Tuberculosis Diagnosis and for NGS

This tender, identified by reference number 20260240, is for the acquisition of specialized reagents. The procurement specifically targets reagents required for two critical applications: the diagnosis of Tuberculosis (TB) and Next-Generation Sequencing (NGS). This suggests the contracting entity is involved in advanced diagnostic or research activities. For TB diagnosis, the reagents will likely be used in molecular or immunoassay-based testing methods. For NGS, the reagents are essential for library preparation and sequencing processes, enabling large-scale genomic analysis. The tender seeks suppliers capable of providing high-quality, reliable reagents that meet stringent performance standards for both diagnostic and research purposes. Bidders must clearly outline the specifications of the reagents they offer, including compatibility with existing laboratory equipment, shelf life, and performance data. The evaluation will focus on the technical suitability of the reagents, the supplier's track record, and the overall value for money. This acquisition is crucial for supporting public health initiatives related to TB control and advancing genomic research capabilities.

This is a supplies contract in the health and medical services, Research and information and communication technology sectors, with a focus on Infectious Diseases, Laboratory and Laboratories. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 323,505.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.